Funding Agency

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007315-009
Application #
2299761
Study Section
Project Start
1990-02-16
Project End
1995-02-15
Budget Start
1993-10-08
Budget End
1994-02-15
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost

  Institution

Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205

  Publications

O'Dwyer, P J; Moyer, J D; Suffness, M et al. (1994) Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. Cancer Res 54:724-9
Plowman, J; Waud, W R; Koutsoukos, A D et al. (1994) Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 54:3793-9
Waud, W R; Plowman, J; Harrison Jr, S D et al. (1992) Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice. Cancer Chemother Pharmacol 30:261-6
Waud, W R; Gilbert, K S; Harrison Jr, S D et al. (1992) Cross-resistance of drug-resistant murine P388 leukemias to taxol in vivo. Cancer Chemother Pharmacol 31:255-7
Waud, W R; Harrison Jr, S D; Gilbert, K S et al. (1991) Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia. Cancer Chemother Pharmacol 27:456-63